Evidence map›Paper›PMID 26637979›Full record

ArticleAmerican journal of human genetics2015

SLC39A8 Deficiency: A Disorder of Manganese Transport and Glycosylation.

Julien H Park, Max Hogrebe, Marianne Grüneberg, Ingrid DuChesne, Ava L von der Heiden, Janine Reunert, Karl P Schlingmann, Kym M Boycott, Chandree L Beaulieu, Aziz A Mhanni and 14 more

Open access · bronzeAbstract readCase Reports
In one paragraph

Article in American journal of human genetics, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 180 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
180citing papers in PubMed, 2 pooled it
16.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

180 citing papers in PubMed, 2 syntheses or guidelines pooled it, 304 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Functional characterization of a novel ZIP8 variant causing impaired manganese homeostasis and congenital disorders of glycosylation.Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine · 2026
    Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Removal of Toxic Metabolites-Chelation: Manganese Disorders.Journal of inherited metabolic disease · 2025
    Review
  18. SLC39A8-mediated zinc dyshomeostasis potentiates kidney disease.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  19. Metal Transporter GeneNutrients · 2025
    Article
  20. Article

120 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors at 8 institutions in 4 countries.

Julien H ParkUniversitätsklinikum Münster, Klinik und Poliklinik für Kinder- und Jugendmedizin, Albert-Schweitzer-Campus 1, Gebäude A 1, 48149 Münster, Germany.
Max HogrebeUniversitätsklinikum Münster, Klinik und Poliklinik für Kinder- und Jugendmedizin, Albert-Schweitzer-Campus 1, Gebäude A 1, 48149 Münster, Germany.
Marianne GrünebergUniversitätsklinikum Münster, Klinik und Poliklinik für Kinder- und Jugendmedizin, Albert-Schweitzer-Campus 1, Gebäude A 1, 48149 Münster, Germany.
Ingrid DuChesneUniversitätsklinikum Münster, Klinik und Poliklinik für Kinder- und Jugendmedizin, Albert-Schweitzer-Campus 1, Gebäude A 1, 48149 Münster, Germany.
Ava L von der HeidenUniversitätsklinikum Münster, Klinik und Poliklinik für Kinder- und Jugendmedizin, Albert-Schweitzer-Campus 1, Gebäude A 1, 48149 Münster, Germany.
Janine ReunertUniversitätsklinikum Münster, Klinik und Poliklinik für Kinder- und Jugendmedizin, Albert-Schweitzer-Campus 1, Gebäude A 1, 48149 Münster, Germany.
Karl P SchlingmannUniversitätsklinikum Münster, Klinik und Poliklinik für Kinder- und Jugendmedizin, Albert-Schweitzer-Campus 1, Gebäude A 1, 48149 Münster, Germany.
Kym M BoycottChildren's Hospital of Eastern Ontario Research Institute, University of Ottawa, Ottawa, ON K1H 8L1, Canada.
Chandree L BeaulieuChildren's Hospital of Eastern Ontario Research Institute, University of Ottawa, Ottawa, ON K1H 8L1, Canada.
Aziz A MhanniGenetics and Metabolism Program, Children's Hospital and the Department of Pediatrics and Child Health, University of Manitoba, Winnipeg, MB R3A 1S1, Canada.
A Micheil InnesDepartment of Medical Genetics & Alberta Children's Hospital Research Institute, Cumming School of Medicine, University of Calgary, Calgary, AB T2N 4N1, Canada.
Konstanze HörtnagelCeGaT GmbH, Paul-Ehrlich-Str. 23, 72076 Tübingen, Germany.
Saskia BiskupCeGaT GmbH, Paul-Ehrlich-Str. 23, 72076 Tübingen, Germany.
Eva M GleixnerCeGaT GmbH, Paul-Ehrlich-Str. 23, 72076 Tübingen, Germany.
Gerhard KurlemannUniversitätsklinikum Münster, Klinik und Poliklinik für Kinder- und Jugendmedizin, Albert-Schweitzer-Campus 1, Gebäude A 1, 48149 Münster, Germany.
Barbara FiedlerUniversitätsklinikum Münster, Klinik und Poliklinik für Kinder- und Jugendmedizin, Albert-Schweitzer-Campus 1, Gebäude A 1, 48149 Münster, Germany.
Heymut OmranUniversitätsklinikum Münster, Klinik und Poliklinik für Kinder- und Jugendmedizin, Albert-Schweitzer-Campus 1, Gebäude A 1, 48149 Münster, Germany.
Frank RutschUniversitätsklinikum Münster, Klinik und Poliklinik für Kinder- und Jugendmedizin, Albert-Schweitzer-Campus 1, Gebäude A 1, 48149 Münster, Germany.
Yoshinao WadaOsaka Medical Center and Research Institute for Maternal and Child Health, 840 Murodo-cho, Izumi, Osaka 594-1101, Japan.
Konstantinos TsiakasUKE, Universitätskinderklinik, Martinistr. 52, 20246 Hamburg, Germany.
René SanterUKE, Universitätskinderklinik, Martinistr. 52, 20246 Hamburg, Germany.
Daniel W NebertDepartment of Pediatrics & Molecular Developmental Biology, Division of Human Genetics, Cincinnati Children's Hospital, Cincinnati, OH 45229, USA; Department of Environmental Health, University of Cincinnati College of Medicine, Cincinnati, OH 45267, USA.
Stephan RustUniversitätsklinikum Münster, Klinik und Poliklinik für Kinder- und Jugendmedizin, Albert-Schweitzer-Campus 1, Gebäude A 1, 48149 Münster, Germany.
Thorsten MarquardtUniversitätsklinikum Münster, Klinik und Poliklinik für Kinder- und Jugendmedizin, Albert-Schweitzer-Campus 1, Gebäude A 1, 48149 Münster, Germany. Electronic address: thorsten.marquardt@ukmuenster.de.
Klinik und Poliklinik für Kinder- und Jugendmedizin · DECeGaT (Germany) · DEUniversität Hamburg · DEUniversity of Ottawa · CACincinnati Children's Hospital Medical Center · USOsaka International Cancer Institute · JPUniversity of Calgary · CAUniversity of Manitoba · CA

Funding

REPRODUCTIVE AND DEVELOPMENTAL TOXICOLOGY RESEARCHP30ES006096 · NIEHS · UNIVERSITY OF CINCINNATI · PI PINNEY, SUSAN MENGEL · 1992 to 2022
$35.4M
MOLECULAR GENETICS OF CD TOXICITYR01ES010416 · NIEHS · UNIVERSITY OF CINCINNATI · PI NEBERT, DANIEL W. · 2000 to 2010
$3.4M
NIEHS NIH HHS P30 ES006096NIEHS NIH HHS P30 ES06096NIEHS NIH HHS R01 ES010416
6 · The paper itself

Abstract

SLC39A8 is a membrane transporter responsible for manganese uptake into the cell. Via whole-exome sequencing, we studied a child that presented with cranial asymmetry, severe infantile spasms with hypsarrhythmia, and dysproportionate dwarfism. Analysis of transferrin glycosylation revealed severe dysglycosylation corresponding to a type II congenital disorder of glycosylation (CDG) and the blood manganese levels were below the detection limit. The variants c.112G>C (p.Gly38Arg) and c.1019T>A (p.Ile340Asn) were identified in SLC39A8. A second individual with the variants c.97G>A (p.Val33Met) and c.1004G>C (p.Ser335Thr) on the paternal allele and c.610G>T (p.Gly204Cys) on the maternal allele was identified among a group of unresolved case subjects with CDG. These data demonstrate that variants in SLC39A8 impair the function of manganese-dependent enzymes, most notably β-1,4-galactosyltransferase, a Golgi enzyme essential for biosynthesis of the carbohydrate part of glycoproteins. Impaired galactosylation leads to a severe disorder with deformed skull, severe seizures, short limbs, profound psychomotor retardation, and hearing loss. Oral galactose supplementation is a treatment option and results in complete normalization of glycosylation. SLC39A8 deficiency links a trace element deficiency with inherited glycosylation disorders.

Indexed as

Amino Acid SequenceCarbohydrate SequenceCations, DivalentCation Transport ProteinsCongenital Disorders of GlycosylationDwarfismFemaleGalactoseGene ExpressionHigh-Throughput Nucleotide SequencingHumansInfantIon TransportManganeseMolecular Sequence DataMutationCations, DivalentCation Transport ProteinsGalactoseManganeseSLC39A8 protein, human

Identifiers

PMID26637979
PMCPMC4678430
OpenAlexW2181502677

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.